CWBHF: AI 评分 51/100 — AI 分析 (4月 2026)

Charlotte's Web Holdings, Inc. focuses on producing and distributing hemp-derived cannabidiol (CBD) wellness products. The company's diverse product range includes tinctures, gummies, capsules, and topicals marketed under brands like Charlotte's Web and CBD Medic.

Key Facts: AI Score: 51/100 Sector: Healthcare

公司概况

概要：

Charlotte's Web Holdings, Inc. cultivates, manufactures, and distributes hemp-derived CBD wellness products, including tinctures, gummies, and topicals, targeting both human and pet markets through retail and online channels, while navigating a complex regulatory landscape in the specialty drug sector.

CWBHF是做什么的？

Founded in 2013 and headquartered in Denver, Colorado, Charlotte's Web Holdings, Inc. emerged as a prominent player in the burgeoning hemp-derived CBD market. Originally known as Stanley Brothers Holdings Inc., the company rebranded in 2018 to Charlotte's Web Holdings, Inc. The company's origins are rooted in providing CBD products to individuals seeking natural wellness solutions. Charlotte's Web cultivates hemp and manufactures a range of CBD products, including hemp extract oil tinctures, gummies, capsules, and topical creams and lotions. These products are marketed under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. The company's products contain phytocannabinoids, including CBD, cannabichromene, cannabigerol, and cannabinol, along with terpenes and flavonoids. Charlotte's Web distributes its products through retail outlets, healthcare practitioners, and its online platform. The company also engages in research and development through its CW Labs division, collaborating with institutions like the University at Buffalo and McLean Hospital to advance hemp cannabinoid science.

CWBHF的投资论点是什么？

Charlotte's Web Holdings, Inc. operates in the evolving CBD wellness market. The company's diverse product portfolio and established brand presence are key value drivers. Growth catalysts include expanding retail partnerships and continued product innovation. However, the company faces risks related to regulatory uncertainty and competition within the CBD industry. With a market capitalization of $0.10 billion and a negative P/E ratio of -4.57, the company's profitability remains a concern. Investors should monitor the company's ability to achieve profitability and navigate the regulatory landscape to capitalize on the growing demand for CBD products. The company's gross margin of 44.3% indicates potential for improved profitability with scale.

CWBHF在哪个行业运营？

Charlotte's Web Holdings, Inc. operates within the rapidly growing CBD market, driven by increasing consumer awareness and acceptance of CBD products for wellness purposes. The industry is characterized by intense competition, evolving regulations, and varying product quality standards. Charlotte's Web differentiates itself through its established brand, diverse product portfolio, and commitment to research and development. The company competes with other CBD manufacturers and distributors, as well as pharmaceutical companies exploring cannabinoid-based therapies. Navigating the regulatory landscape and ensuring product quality are critical for success in this dynamic market.

Drug Manufacturers - Specialty & Generic

Healthcare

CWBHF有哪些增长机遇？

Expansion of Retail Partnerships: Charlotte's Web can drive growth by expanding its distribution network through partnerships with major retailers. The increasing acceptance of CBD products in mainstream retail channels presents a significant opportunity to reach a broader customer base. Securing shelf space in national chains and regional retailers can significantly boost sales volume and brand visibility. The timeline for realizing this growth opportunity is immediate and ongoing, as the company continues to pursue and cultivate retail partnerships. This strategy leverages the growing market demand for accessible CBD products.
Product Innovation and Diversification: Investing in research and development to create new and innovative CBD products can drive growth. Developing targeted formulations for specific health conditions, such as sleep, stress, and pain management, can attract new customers and increase market share. Expanding the product line to include novel delivery methods, such as transdermal patches or inhalers, can also differentiate Charlotte's Web from competitors. The timeline for this growth opportunity is medium-term, requiring ongoing investment in R&D and clinical trials. The potential market size for targeted CBD formulations is substantial, driven by the increasing demand for personalized wellness solutions.
Strategic Acquisitions and Partnerships: Acquiring complementary businesses or forming strategic partnerships can accelerate growth and expand market reach. Acquiring smaller CBD brands with unique product offerings or established customer bases can provide access to new markets and distribution channels. Partnering with pharmaceutical companies or healthcare providers can facilitate the development and commercialization of cannabinoid-based therapies. The timeline for this growth opportunity is medium to long-term, requiring careful evaluation of potential targets and partners. The potential market size for cannabinoid-based therapies is significant, driven by the increasing interest in natural alternatives to traditional pharmaceuticals.
International Expansion: Expanding into international markets can drive growth by tapping into new customer bases and revenue streams. The global CBD market is growing rapidly, with significant opportunities in Europe, Asia, and Latin America. Adapting product formulations and marketing strategies to meet local regulations and consumer preferences is crucial for success. The timeline for this growth opportunity is long-term, requiring careful planning and execution. The potential market size for CBD products in international markets is substantial, driven by the increasing global awareness of CBD's potential health benefits.
Direct-to-Consumer (DTC) Channel Optimization: Enhancing the company's online presence and DTC capabilities can drive growth by increasing customer engagement and sales. Investing in website optimization, digital marketing, and customer relationship management (CRM) can improve the customer experience and drive conversions. Offering personalized product recommendations, subscription services, and loyalty programs can increase customer retention and lifetime value. The timeline for this growth opportunity is immediate and ongoing, as the company continuously refines its DTC strategy. The potential market size for online CBD sales is significant, driven by the increasing trend of online shopping and the convenience of DTC channels.

Market capitalization of $0.10 billion reflects the company's current valuation in the competitive CBD market.
Gross margin of 44.3% indicates the company's ability to generate revenue from its products after accounting for the cost of goods sold.
Negative P/E ratio of -4.57 suggests the company is currently unprofitable, requiring further analysis of its financial performance.
The company's beta of 2.41 indicates higher volatility compared to the overall market, suggesting a riskier investment.
The company's collaboration with the University at Buffalo and McLean Hospital highlights its commitment to research and development in the CBD space.

CWBHF提供哪些产品和服务？

Cultivates hemp plants for CBD extraction.
Manufactures hemp-derived CBD wellness products.
Produces CBD oil tinctures, gummies, capsules, and topicals.
Markets products under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands.
Distributes products through retail outlets, healthcare practitioners, and online.
Conducts research and development to advance hemp cannabinoid science.
Collaborates with universities and hospitals on research programs.

CWBHF如何赚钱？

Cultivates hemp and extracts CBD.
Manufactures and sells CBD products through various channels.
Generates revenue through retail sales, online sales, and partnerships.
Invests in research and development to innovate and improve products.

Individuals seeking natural wellness solutions.
Retail consumers purchasing CBD products online and in stores.
Healthcare practitioners recommending CBD products to patients.
Pet owners seeking CBD products for their pets.

Established brand recognition and reputation in the CBD market.
Proprietary hemp genetics and cultivation practices.
Diverse product portfolio catering to various customer needs.
Strong distribution network through retail, online, and healthcare channels.

什么因素可能推动CWBHF股价上涨？

Ongoing: Expansion of retail partnerships to increase product distribution and market reach.
Ongoing: Product innovation and diversification to cater to evolving consumer preferences and health needs.
Upcoming: Potential regulatory changes in the CBD industry that could impact market access and product labeling.
Ongoing: Research and development efforts to validate the efficacy and safety of CBD products.
Ongoing: International expansion initiatives to tap into new markets and revenue streams.

CWBHF的主要风险是什么？

Ongoing: Regulatory uncertainty and evolving legal landscape surrounding CBD products.
Ongoing: Intense competition from other CBD manufacturers and distributors.
Potential: Fluctuations in hemp prices and supply chain disruptions.
Potential: Changing consumer preferences and market trends.
Potential: Negative publicity or adverse events related to CBD products.

CWBHF的核心优势是什么？

Established brand recognition
Diverse product portfolio
Strong distribution network
Commitment to research and development

CWBHF的劣势是什么？

Negative profitability
High beta indicating volatility
Dependence on evolving regulatory landscape
Intense competition in the CBD market

CWBHF有哪些机遇？

Expansion of retail partnerships
Product innovation and diversification
Strategic acquisitions and partnerships
International expansion

CWBHF面临哪些威胁？

Regulatory uncertainty
Increased competition
Fluctuations in hemp prices
Changing consumer preferences

CWBHF的竞争对手是谁？

Avicanna Inc. — Focuses on cannabinoid-based pharmaceuticals. — (AVCNF)
Canopy Rivers Inc. — Venture capital firm investing in cannabis companies. — (CAAOF)
Columbia Care Inc. — Operates medical cannabis dispensaries and cultivation facilities. — (CNTMF)
1933 Industries Inc. — Vertically integrated cannabis company. — (EOFBF)
FinCanna Capital Corp. — Provides financing to cannabis companies. — (FNCH)

Key Metrics

MoonshotScore: 51/100

Company Profile

CEO: William J. Morachnick
Headquarters: Louisville, US
Employees: 112
Founded: 2018

AI Insight

AI analysis pending for CWBHF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Charlotte's Web Holdings, Inc. do?

Charlotte's Web Holdings, Inc. is a vertically integrated company that cultivates hemp and manufactures hemp-derived CBD wellness products. The company's product portfolio includes CBD oil tinctures, gummies, capsules, and topicals marketed under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. These products are distributed through retail outlets, healthcare practitioners, and the company's online platform. Charlotte's Web focuses on providing natural wellness solutions to consumers and pets, while also investing in research and development to advance hemp cannabinoid science.

What do analysts say about CWBHF stock?

AI analysis is currently pending for CWBHF. Generally, analysts may consider factors such as the company's revenue growth, profitability, market share, and regulatory environment when evaluating the stock. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Key valuation metrics to monitor include the company's price-to-sales ratio, price-to-book ratio, and enterprise value-to-EBITDA multiple. Growth considerations include the company's ability to expand its distribution network, innovate new products, and navigate the evolving regulatory landscape.

What are the main risks for CWBHF?

Charlotte's Web Holdings, Inc. faces several risks, including regulatory uncertainty, intense competition, fluctuations in hemp prices, and changing consumer preferences. The evolving legal landscape surrounding CBD products poses a significant risk, as changes in regulations could impact market access and product labeling. Increased competition from other CBD manufacturers and distributors could erode market share and pricing power. Fluctuations in hemp prices and supply chain disruptions could impact the company's cost of goods sold and profitability. Changing consumer preferences and market trends could require the company to adapt its product offerings and marketing strategies.